VICO — Vicore Pharma Holding AB Balance Sheet
0.000.00%
Last trade - 00:00
- SEK1.93bn
- SEK1.45bn
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Cash | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 265 | 319 | 371 | 262 | 483 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 1.43 | 5.35 | 1.42 | 2.18 | 3.24 |
Prepaid Expenses | |||||
Total Current Assets | 267 | 328 | 378 | 270 | 496 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 0.332 | 0.252 | 0.401 | 0.117 | 0.025 |
Net Intangible Assets | |||||
Long Term Investments | |||||
Other Long Term Assets | |||||
Total Assets | 341 | 407 | 451 | 338 | 498 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 17 | 48.1 | 65.7 | 46.4 | 41 |
Capital Lease Obligations | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Deferred Income Tax | |||||
Total Other Liabilities | |||||
Total Liabilities | 19.5 | 52 | 67.9 | 48.9 | 42.4 |
Common Stock | |||||
Retained Earnings (Accumulated Deficit) | |||||
Other Equity | |||||
Total Equity | 322 | 355 | 383 | 289 | 455 |
Total Liabilities & Shareholders' Equity | 341 | 407 | 451 | 338 | 498 |
Total Common Shares Outstanding |